Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司
Pay for financial year ended 2021-12-31
Source: Annual report
Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Ren, Jinsheng 任晉生 | Ch, CEO, Fdr | 1,508 | 360 | 45 | 1,913 | ||
| 2 | Song, Rui Lin 宋瑞霖 | INED | 360 | 360 | ||||
| 3 | Tang, Renhong 唐任宏 | ED, SVP | 2,029 | 2,606 | 3 | 5,910 | 10,548 | |
| 4 | Wan, Yushan 萬玉山 | FD | 1,070 | 1,360 | 35 | 4,295 | 6,760 | |
| 5 | Wang, Jianguo (Huitongda) 汪建國 | INED | 360 | 360 | ||||
| 6 | Wang, Xinhua (1955) 王新華 | INED | 360 | 360 | ||||
| 7 | Zhang, Cheng (1974) 張誠 | ED, COO | 856 | 560 | 9 | 1,425 | ||
| 8 | Zhao, John Huan 趙令歡 | NED | ||||||
| Total | 1,080 | 5,463 | 4,886 | 92 | 10,205 | 21,726 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,440 | 11,740 | 3,323 | 217 | 50,820 | 67,540 | Report |
| 2023-12-31 | 1,440 | 11,602 | 13,532 | 183 | 7,327 | 34,084 | Report |
| 2022-12-31 | 1,080 | 6,168 | 16,931 | 143 | 11,130 | 35,452 | Report |
| 2021-12-31 | 1,080 | 5,463 | 4,886 | 92 | 10,205 | 21,726 | Report |
| 2020-12-31 | 1,080 | 7,702 | 7,384 | 96 | 7,461 | 23,723 | Report |
| Total | 6,120 | 42,675 | 46,056 | 731 | 86,943 | 182,525 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy